Accendra Health (ACH) Capital Expenditures (2009 - 2026)

Accendra Health (ACH) has 18 years of Capital Expenditures data on file, last reported at $72.0 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $72.0 million, up 57.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.7 million (down 66.76% YoY), and the FY2025 annual result was $44.5 million, down 73.88% from the prior year.
• Capital Expenditures grew to $72.0 million in Q1 2026 per ACH's latest filing, from -$133.3 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $167.2 million in Q3 2025 and troughed at -$133.3 million in Q4 2025.
• A 5-year average of $36.3 million and a median of $45.8 million in 2025 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 6206.72% in 2022 and fell as far as 2748.64% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $152.2 million in 2022, then tumbled by 79.05% to $31.9 million in 2023, then tumbled by 30.23% to $22.3 million in 2024, then plunged by 699.14% to -$133.3 million in 2025, then soared by 154.0% to $72.0 million in 2026.
• Business Quant data shows ACH's Capital Expenditures at $72.0 million in Q1 2026, -$133.3 million in Q4 2025, and $167.2 million in Q3 2025.